Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Smoking Cessation 1Smoking 1Neoplasms 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Nicotine × 1 year × Clear all
NCT05535192 2026-04-23

THRIVE-65

Dana-Farber Cancer Institute

Phase NA Recruiting
270 enrolled
Breast

Breast Neoplasms

NCT06218823 2025-10-27

Tobacco Treatment Comparison for Cancer Care

University of Wisconsin, Madison

Phase 4 Completed
52 enrolled 9 charts

Neoplasms, Smoking Cessation

NCT04200534 2025-08-22

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
358 enrolled
Thoracic

Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡